Gagnon Robert E.
Reporting owner on Forms 3, 4 and 5, CIK 1504983.
Gagnon Robert E. reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-09-30.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Bone Biologics Corp CIK 1419554 | director | 1 | 2026-09-30 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Bone Biologics Corp Non-Employee Stock Option, derivative | 2026-09-28 | A granted | +113,896 | $0 | 113,896 | Form 4 |
| Bone Biologics Corp Non-Employee Stock Option, derivative, holding | 10,483 | Form 4 | ||||
| Bone Biologics Corp Non-Employee Stock Option, derivative, holding | 5,119 | Form 4 | ||||
| Bone Biologics Corp Non-Employee Stock Option, derivative, holding | 2 | Form 4 | ||||
| Bone Biologics Corp Non-Employee Stock Option, derivative, holding | 1,335 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001493152-26-045149 | Bone Biologics Corp | 2026-09-30 |